Editas Medicine Competitors and Similar CompaniesClear all

Biocytogen Boston's competitors and similar companies include Amyris, Caribou Biosciences and Nuclera.

	Biocytogen Boston Biocytogen Boston is a company that provides antibody drug development solutions.	Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.	Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.	Nuclera Nuclera is a company that specializes in DNA synthesis.
Founding Date	Founding Date 2008	Founding Date 2003	Founding Date 2012	Founding Date 2013
Type	Type Subsidiary	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics
Locations	Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US	Locations Emeryville, US HQ Sao Paulo, BR	Locations Berkeley, US HQ	Locations Cambridge, GB HQ
Employees	Employees 1833% increase	Employees 1,0031% decrease	Employees 1477% decrease	Employees 1192% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $269.8m (FY, 2022)	Revenue (est.) $11.2m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($543.4m) (FY, 2022)	Net income ($148.1m) (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 34m (about 7 years ago)	Latest funding round N/A	Latest funding round $ 10m (over 7 years ago)
Total funding raised	Total funding raised $ 284.3m	Total funding raised $ 551.9m	Total funding raised $ 159.5m	Total funding raised $ 11.3m